Frontage Achieves ISO/IEC 27001:2022 Certified
EXTON, PA., June 5, 2025 –As a demonstration of commitment to our customers and business partners, our IT takes threats to the availability, integrity, and confidentiality of our clients’ information seriously. As such, we have continued to be an ISO/IECISO/IEC 27001:2022 certified provider whose Information Security Management System (ISMS) has received third-party accreditation from the International Standards Organization.
ISO/IEC 27001:2022 is an information security management system standard revised most recently in 2022 by the International Organization for Standardization (ISO) and the International Electrotechnical Commission (IEC).
A-LIGN, an independent, third-party auditor, found Frontage to have technical controls in place and formalized IT Security policies and procedures. A-LIGN is an ISO / IEC 27001 certification body accredited by the ANSI National Accreditation Board (ANAB) to perform ISMS 27001 certifications. Frontage IT has implemented several security measures and countermeasures that protect it from unauthorized access or compromise and IT personnel were found to be conscientious and knowledgeable in best practices.
Compliance with this internationally recognized standard confirms that Frontage’s security management program is comprehensive and follows leading practices.
The scope of our ISO/IEC 27001:2022 certification includes the hosting, operation and management of IT systems supporting drug discovery and clinical services enabled and managed by the corporate IT function, including processing, storing, monitoring, EXCHANGE, and destruction of information by the company, for the company and its customers at the following sites:
- Exton
- Concord
- Secaucus
- Hayward
This certification demonstrates the Frontage’s continued commitment to information security at every level and ensures you that the security of client data and information has been addressed, implemented, and properly controlled in the in-scope areas of our organization. Certificate Frontage Laboratories 2025 ISO 27001.2022
About Frontage ( www.frontagelab.com )
Frontage Holdings Corp (1521.HK), together with its wholly owned subsidiaries, including Frontage Laboratories, Inc., is a global Contract Research Organization (CRO) that provides integrated, science-driven, product development services from drug discovery to late-phase clinical process to enable biopharmaceutical companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment, and early-phase clinical studies. Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of new molecules through development and to successfully file global regulatory submissions. For more details visit Frontage Laboratories, Inc..